Overview

Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy

Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The goal of this randomized controlled, double-blinded trial is to assess the efficacy of intravenous tranexamic acid, a drug, in reducing blood loss and transfusion in patients undergoing periacetabular osteotomy, an elective reorientation procedure for the hip joint. The investigators hypothesize that tranexamic acid will be more effective than placebo (normal saline solution) in reducing blood loss and transfusion after periacetabular osteotomy.
Phase:
N/A
Details
Lead Sponsor:
Hospital for Special Surgery, New York
Treatments:
Tranexamic Acid